Asia-Pacific deep brain stimulation systems market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
By Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), Application (Obsessive Compulsive Disorder, Parkinson's Disease, Essential Tremor, Epilepsy, Dystonia), Type (Rechargeable, Non-Rechargeable), End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific)
Some of the major factors contributing to the growth of the market are:
- New and advance deep brain stimulator launches.
- Improving healthcare infrastructure.

Market Players:

The key market players for Asia-Pacific deep brain stimulation systems market are listed below:

- Medtronic
- Boston Scientific Corporation
- Abbott
- Aleva Neurotherapeutics SA
- Neuropace, Inc.
- Beijing Pins Medical Co., Ltd.
- Sceneray Corporation, Limited
- Fisher Wallace